Containers & Packaging company Mold-Tek Packaging announced Q4FY26 & FY26 results Financial Highlights: The company reported Revenue from Operations of Rs 23,785.56 lakh in Q4FY26, representing a growth of 17.27% YoY from Rs 20,260.82 lakh and a growth of 19.86% QoQ from Rs 19,843.68 lakh. For FY26, revenue stood at Rs 88,660.95 lakh, up 13.48% YoY compared to Rs 78,131.96 lakh in FY25. Net Profit (PAT) for Q4FY26 was Rs 2,064.06 lakh, up 26.88% YoY from Rs 1,626.80 lakh and up 43.82% QoQ from Rs 1,435.20 lakh. For FY26, PAT reached Rs 7,287.42 lakh, representing a growth of 20.35% YoY. Profit Before Tax (PBT) in Q4FY26 was Rs 2,782.27 lakh, up 25.18% YoY from 2,222.67 lakh. For FY26, PBT increased by 20.25% to Rs 9,773.19 lakh from Rs 8,127.15 lakh. EBIDTA per kg for FY26 increased to Rs 40.74 from Rs 37.60 in FY25, reflecting a growth of 8.24%. In Q4FY26, EBIDTA per kg stood at Rs 42.11. Sales volumes For FY26 grew by 11.39% to 42,629 MT compared to 38,264 MT in FY25. Q4FY26 sales volume increased by 17.37% to 11,424.58 MT. The company reported Other Income of Rs 125.34 lakh for FY26 compared to Rs 24.53 lakh in FY25. Total Assets of the company increased to Rs 1,05,822.17 lakh as of March 31, 2026, from Rs 93,690.47 lakh in the previous year. Business Highlights: Segment Performance: Pharma Packs: This segment recorded an exceptional volume growth of 208.96% in FY26, achieving a turnover of Rs 35 crore. FMCG Packs: The segment continued its robust growth trajectory with volume growth of 18.04%. Q-Packs: This segment registered a volume growth of 25.82% during the year. Paint Packs: The segment delivered a healthy volume growth of 14.41% in FY26. Lubes Packs: This segment witnessed a volume decline of 12.99% during the period. Operational Consolidation: The company consolidated 5 units in Hyderabad into 2 efficient units (Unit-1 and Unit-10) to improve operational efficiency and capacity utilization. Capacity Expansion: Production capacity was considerably increased at Panipat, Satara, and Cheyyar to meet rising demand from the Aditya Birla Group. Project Update: 50% of the construction of the new factory building at Mahad for Grasim Industries has been completed, with supplies expected to commence from Q2FY27. New Product Launch: Launched effervescent tubes with IML (In-Mold Labeling) for the first time in India in various sizes. Dividend: The Board recommended a final dividend of Rs 2.70 per equity share (27%) for FY26. This is in addition to the interim dividend of Rs 2.00 per equity share (40%) already paid. New Orders: Successfully bagged new orders from reputed companies, including Aadharsh Chemicals, Coromandel Internal, Anatha Food, and DifGen Pharmaceuticals. Infrastructure: Added 28 CRC assembling machines and 1 IBM machine during the year to enhance manufacturing capabilities. J. Lakshmana Rao, Chairman & Managing Director, said: ”The consolidation of 5 units in Hyderabad into 2 units and better capacity utilisation has improved the company’s performance, which will be felt fully from next financial year onwards. The West Asia war resulted in a steep increase in raw material prices; however, Mold-Tek Packaging Limited was able to convince all its clients for quicker and full absorption of the price hike. The Company expects to continue its growth trajectory in FY27, supported by significant contributions from the Panipat plant in Thinwall and Square Pack sales, along with better capacity utilization across the three ABG plants. The Company is also confident of crossing a turnover of Rs 1,000 crore during FY27. To meet the increased demand and growth and enhance manufacturing capabilities, the Company added 28 CRC assembling machines along with a IBM machine during the year. Effervescent tubes launched with IML (First time in India) for 85,99,120,144 mm sizes. The Pharma Packaging business continues to witness strong traction due to increasing focus on qualitydriven and compliant packaging solutions in the pharmaceutical sector. The Company is also actively expanding its customer base and product portfolio in this segment, which is expected to contribute significantly to future growth and profitability. Company has plans to expand its pharma packaging capacity during the FY27, with wider range of products." Result PDF